Hans Prenen hoogleraar

Publicaties Hans Prenen

Highlights in gastro-intestinal cancer

Bron
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Auteur(s)

Phase I safety, efficacy, and biomarker response evaluations of three oral PD-L1 inhibitors : INCB086550, INCB099280, and INCB099318

Bron
Journal for ImmunoTherapy of Cancer - ISSN 2051-1426-14:8 (2026) p.
Auteur(s)
    Hans Prenen, Sylvie Rottey, David J. Pinato, Thierry Lesimple, Eric Van Cutsem, Marie Robert, Rachel Galot, Sarina A. Piha-Paul, Pascale Tomasini, Nuria Kotecki, Rebecca Kristeleit, Christophe Le Tourneau, Ruth Plummer, Udai Banerji, Tarek Meniawy, Jason Howe, Jeannie Daniel, Jennifer Pulini, Susan Spitz, Xiaohua Gong, Molly Halloran, Antoine Italiano

Afatinib for advanced cancers carrying an EGFR, HER2, or HER3 mutation : an open-label, phase II, Belgian precision study

Bron
JCO Precision Oncology - ISSN 2473-4284-10:7 (2026) p.
Auteur(s)
    Lore Decoster, Philippe Aftimos, Sylvie Rottey, Hans Prenen, Joelle Collignon, Jeroen Mebis, Jean Luc Canon, Vanessa Fastenaekels, Nadia Cappoen, Anna Kondrat, Sofie Joris, Jacques De Greve

Amivantamab monotherapy in chemorefractory RAS/BRAF wild-type metastatic colorectal cancer : results from OrigAMI-1, an open-label, phase Ib/II study

Bron
Journal of clinical oncology - ISSN 0732-183X-44:17 (2026) p. 1624-1634
Auteur(s)
    Paul E. Oberstein, J. Randolph Hecht, Kanwal Raghav, Filippo Pietrantonio, Dirk Arnold, Victor Moreno, Eric Van Cutsem, Rozita Abdul Malik, Yong Sang Hong, Myung Ah Lee, Harvey Yu-Li Su, Jeeyun Lee, Sreenivasa Chandana, Marcia Cruz-Correa, Ying Yuan, Azura Ahmad, Kuan-Ming Lai, Hung-Chih Hsu, Eric Xueyu Chen, Elena Elez, Chia-Chi Lin, Carlos Lopez, Hans Prenen, Susana Rosello-Keranen, Hector Velez, Yu-Min Yeh, Volker Heinemann, Cathy Eng, Seung-Hoon Beom, Sabine Tejpar, Sanjib Chowdhury, Xuesong Lyu, Medha Kamat, Joshua C. Curtin, Bharvin Patel, John Xie, Rianka Bhattacharya, Robert W. Schnepp, Emrullah Yilmaz, Ryota Iwasawa, Mahesh Daksh, Patricia Lorenzini, Meena Thayu, Mahadi Baig, Han Sang Kim, Sae-Won Han

Phase I study of mosperafenib, a novel paradox breaker B-Raf proto-oncogene serine/threonine kinase (BRAF) inhibitor, in patients with BRAF V600-mutant solid tumors

Bron
Journal of clinical oncology - ISSN 0732-183X-44:14 (2026) p. 1337-1348
Auteur(s)
    Maria Vieito, Elisa Fontana, Catherine H. Han, Eduardo Castanon, David J. Pinato, Oliver Bechter, Rikke L. Eefsen, Irene Moreno, Hans Prenen, Reinhard Dummer, Ruth Plummer, Gabriel Schnetzler, Martin Kornacker, Piergiorgio Pettazzoni, Florian Renner, Mahdi About, Martha L. Serrano-Serrano, Christina Godfried Sie, Abiraj Keelara, Andreas Roller, David Dejardin, Elisa Cinato, Tomi Fakolade, Ernesto Guarin, Nick Flinn, Nicole A. Kratochwil, Nino Keshelava